|
ATG3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.844200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.980500E-03 |
| Normal-vs-Stage2 |
1.130570E-01 |
| Normal-vs-Stage3 |
2.089700E-02 |
| Normal-vs-Stage4 |
2.11479999999709E-05 |
| Stage1-vs-Stage2 |
9.318600E-01 |
| Stage1-vs-Stage3 |
6.652000E-01 |
| Stage1-vs-Stage4 |
1.387700E-02 |
| Stage2-vs-Stage3 |
6.420200E-01 |
| Stage2-vs-Stage4 |
5.521700E-02 |
| Stage3-vs-Stage4 |
1.260590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.998000E-04 |
| Normal-vs-AfricanAmerican |
2.283800E-01 |
| Normal-vs-Asian |
6.262000E-01 |
| Caucasian-vs-AfricanAmerican |
1.434030E-01 |
| Caucasian-vs-Asian |
7.440200E-01 |
| AfricanAmerican-vs-Asian |
8.596000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.983300E-04 |
| Normal-vs-Female |
4.996600E-01 |
| Male-vs-Female |
1.822300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.402900E-03 |
| Normal-vs-Extreme_Weight |
3.952500E-04 |
| Normal-vs-Obese |
1.628020E-02 |
| Normal-vs-Extreme_Obese |
6.003200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.257800E-01 |
| Normal_Weight-vs-Obese |
4.930200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.103400E-01 |
| Extreme_Weight-vs-Obese |
4.385600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.094600E-01 |
| Obese-vs-Extreme_Obese |
7.952000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.724800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.595300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.481700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.014300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.538200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.143800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.283400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.844600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.743800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.065200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.347720E-02 |
| Normal-VS-Type2 PRCC |
4.941200E-03 |
| Normal-VS-KIRP CIMP |
5.903800E-02 |
| Normal-VS-Unclassified PRCC |
1.254780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.767200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.153200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.915600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.034400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.707200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.341600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.216400E-04 |
| Normal-vs-N1 |
2.594100E-02 |
| Normal-vs-N2 |
8.33290000000764E-05 |
| N0-vs-N1 |
4.742600E-01 |
| N0-vs-N2 |
2.347200E-01 |
| N1-vs-N2 |
1.098580E-01 |
|
|
